secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001171843-25-004036
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience out of compliance with Nasdaq audit committee rule after board resignation
--------------------------------------------------------------------------------

- Notified Nasdaq on June 18, 2025 of non-compliance with Listing Rule 5605(c)(2)(A) due to Alan Edrick's resignation.
- Audit Committee now has only two members; one vacancy from Edrick's departure effective June 10, 2025.
- Cure period runs until earlier of next annual meeting or June 10, 2026; company plans to appoint independent director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325004036/0001171843-25-004036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325004036/f8k_062325.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-004036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer